On Sep 7, 2021 Emulate closed a Series E round and raised $82,000,000 from Northpond Ventures, Perceptive Advisors, featuring lead investors Northpond Ventures. About the […]
Post-IPO Equity – Adaptimmune
On Sep 7, 2021 Adaptimmune closed a Post-IPO Equity round and raised $150,000,000 from Genentech, featuring lead investors Genentech. About the company: Adaptimmune is located […]
Pre Seed Round – BreatheIO
On Sep 3, 2021 BreatheIO closed a Pre-Seed round and raised $5,000 from investors, featuring lead investors . About the company: BreatheIO is located at […]
Atos Klinik Heidelberg acquired by Intermediate Capital Group
Sep 1, 2021 Intermediate Capital Group has entered into an agreement to acquire Atos Klinik Heidelberg . Intermediate Capital Group based at London, England, United […]
Series B – Buymed
On Sep 1, 2021 Buymed closed a Series B round and raised $8,800,000 from Cocoon Capital, Nextrans, Smilegate Investment, featuring lead investors Smilegate Investment. About […]
Private Equity Round – Relisys
On Sep 1, 2021 Relisys closed a Private Equity round and raised ₹100,000,000 from Siguler Guff & Company, featuring lead investors Siguler Guff & Company. […]
Fitore acquired by VitroBioPharma
Aug 31, 2021 VitroBioPharma has entered into an agreement to acquire Fitore in a $2,300,000 deal. VitroBioPharma based at Golden, Colorado, United States. “Vitro Biopharma […]
Series D – ARS Pharmaceuticals
On Aug 31, 2021 ARS Pharmaceuticals closed a Series D round and raised $55,000,000 from Deerfield Management, RA Capital Management, SR One, featuring lead investors […]
Series A – Versanis Bio
On Aug 31, 2021 Versanis Bio closed a Series A round and raised $70,000,000 from Aditum Bio, Atlas Venture, Medicxi Ventures, featuring lead investors Atlas […]
Series A – Wellbe
On Aug 31, 2021 Wellbe closed a Series A round and raised $2,000,000 from HealthX Ventures, WISC Partners, featuring lead investors HealthX Ventures. About the […]
